Investigators in Virginia found no cardiovascular or overall mortality benefit in a study of lipid-lowering agents in patients with non-alcoholic fatty liver disease, but a meta-analysis contradicts these results and supports use of statins and agents to lower triglycerides in this population.
The use of statins to treat dyslipidemia and decrease mortality in patients at risk for cardiovascular disease motivated researchers from Inova Fairfax Hospital, in Falls Church, Va., to look into the